MSB 3.21% $1.13 mesoblast limited

Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD, page-101

  1. 6,921 Posts.
    lightbulb Created with Sketch. 1521
    thanks @Royalsandman. May 2022 be a great year for you, too!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.